TrialInternational journal of chronic obstructive pulmonary disease2017

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study.

Jadwiga A Wedzicha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.